← All trials

NCT07196722

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Oct 3, 2025
Primary completion
Sep 19, 2028
Completion date
Oct 6, 2032
First posted
Sep 29, 2025
Last posted
Nov 7, 2025
Enrollment
1092
Arms / groups
8 / —
Source
AACT · ctgov ingestion

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.